Eisler Capital (UK)’s Zura Bio ZURA Stock Holding History

Eisler Capital (UK)’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100,000	Closed	-$820K	–	475
2023 Q2	$820K	Buy	+100,000	New	+$803K	0.01%	314

Other funds holding ZURA

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Eisler Capital (UK)'s ZURA Position: Q3 2023 in Review

Eisler Capital (UK) sold out of Zura Bio (ZURA) in Q3 2023, closing a stake of 100,000 shares — an estimated $820K sold.

Eisler Capital (UK) first reported a position in ZURA in Q2 2023 and held it in 1 quarter. The position peaked at $820K in Q2 2023. 41 funds tracked by Wall St. Rank hold ZURA as of Q3 2023.

Eisler Capital (UK) reported no remaining Zura Bio position as of Q3 2023 after selling out during the quarter.
Eisler Capital (UK) sold 100,000 Zura Bio shares in Q3 2023, an estimated $820K.
Eisler Capital (UK) first reported a position in Zura Bio in Q2 2023 and held it in 1 quarter.
Eisler Capital (UK)'s Zura Bio position peaked at $820K in Q2 2023.
41 funds tracked by Wall St. Rank held Zura Bio as of Q3 2023.

Based on Eisler Capital (UK)'s 13F filing for Q3 2023, filed 13 Nov 2023.